UCSF ranks second in the annual ranking of world universities in clinical medicine and pharmacy by the Academic Ranking of World Universities (ARWU).
May 04, 2012
Academic medical centers can play a larger role in drug development and testing, according to an FDA official, who says there is a need for better strategies to identify winners, minimize costs and reduce failures during drug development.
March 07, 2012
UCSF has launched a new web portal that offers researchers, study coordinators and study participants an easy-on-the-eyes, logically arranged and comprehensive tool that will guide them to a wealth of much-needed information about clinical trials.
January 26, 2012
John Corrin Hutchinson, MD, or “Hutch” to many, professor emeritus and Distinguished Fellow of the American College of Cardiology, passed away peacefully on Jan. 14, 2012. He was 84.
December 02, 2011
As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.
September 29, 2011
It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.
March 15, 2011
UCSF is ranked among the nation’s top four schools for medicine and nursing, according to a new survey conducted by U.S. News & World Report.
February 23, 2011
UCSF pediatric endocrinologist Steve Gitelman leads type 1 diabetes clinical trials with the goal of halting beta cell destruction and thereby stopping the progression of disease soon after it is diagnosed.
January 24, 2011
Current legal restrictions significantly compromise the clinical effectiveness of advance directives, according to a study by researchers at the University of California, San Francisco.
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.